Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...

The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a pivotal ...

A recent Reddit thread on r/HealthInsurance opens with a blunt question: “There’s no more credit reporting on medical debt of any amount since January 2025. Why should I pay any medical bills anymore?

The archaic practice of removing blood from the body to treat a wide range of illnesses lives on today as a standard treatment for certain blood disorders. The modern version of this approach, called ...

Empathy Health Technologies announced Wednesday that it raised $7.6 million to support its Sober Sidekick app, which helps prevent relapse by connecting those struggling with substance use disorder ...

The deadline for extending the Affordable Care Act subsidies is approaching this month. This is happening even as consumers who depend on the ACA Marketplace are faced with the tough decision. Should ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors.

Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...

A Pharvaris drug led to speedy relief and symptom resolution from the sudden swelling attacks caused by a rare genetic disorder, preliminary Phase 3 clinical trial results that pave the way for an FDA ...